Almirall, S.A. (FRA:E2Z)

Market Cap	2.38B
Revenue (ttm)	1.05B
Net Income (ttm)	21.34M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	111.54
Forward PE	32.20
Dividend	0.15 (1.34%)
Ex-Dividend Date	May 15, 2025

Volume	2,200
Average Volume	252
Open	11.14
Previous Close	10.96
Day's Range	11.06 - 11.14
52-Week Range	8.09 - 11.36
Beta	n/a
RSI	53.04
Earnings Date	Nov 10, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Pharmaceutical Preparations
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: E2Z